Harvard Apparatus Regenerative Tech Inc. (HRGN)

[mrinvestor08]

So they have 80 million authorized...current cash on hand will last a bit through third quarter this year...does anybody see a pattern here? They need 12 million a year to survive and they will probably continue diluting the company. On the conference call a few months back they couldn't even estimate how much they need once they file an IND.

Fan of the product...science...saving lives parts but do not like management's lack of clarity and aggressive dilution. Other stocks would be trading at 1 cent if they RS and intend to use all authorized while the shareholders get killed.